Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: Study Protocol.

被引：0
|
作者：
Calais, Jeremie [1 ]
Zhu, Shaojun [1 ]
Hrimas, Nader [2 ]
Eiber, Matthias [3 ]
Hadaschik, Boris [2 ]
Stuschke, Martin [2 ]
Herrmann, Ken [2 ]
Czernin, Johannes [1 ]
Kishan, Amar U. [1 ]
Nickols, Nicholas G. [1 ]
Elashoff, David [1 ]
Fendler, Wolfgang [2 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Essen Gesamthsch, Essen, Germany
[3] TUM, Munich, Germany
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT257
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study
    Kaplan, Irving
    Bubley, Glenn J.
    Bhatt, Rupal S.
    Taplin, Mary-Ellen
    Dowling, Shanna
    Mahoney, Kathleen
    Werner, E.
    Nguyen, Paul
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (05): : 1416 - 1422
  • [32] Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy
    Andruska, Neal
    Fischer-Valuck, Benjamin W.
    Waters, Michael
    Diaz, Elizabeth Juarez
    Agabalogun, Temitope
    Kim, Eric H.
    Smith, Zachary L.
    Brenneman, Randall J.
    Gay, Hiram A.
    Andriole, Gerald L.
    Michalski, Jeff M.
    Baumann, Brian C.
    JOURNAL OF UROLOGY, 2022, 207 (06): : 1227 - 1234
  • [33] PSMA PET/CT to stage high-risk prostate cancer: is already the time to replace conventional imaging?
    Schiavina, Riccardo
    Bianchi, Lorenzo
    Bunocilla, Eugenio
    MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (01): : 135 - 136
  • [34] A multi-center European study to explore the detection of oligometastatic disease by PSMA-PET/CT in intermediate to high-risk Prostate Cancer
    Zuccotti, G.
    Mattana, F.
    Barone, A.
    Muraglia, L.
    Mei, R.
    Farolfi, A.
    Rajwa, P.
    Miszczyk, M.
    Kasivisvanathan, V.
    Zattoni, F.
    Gandaglia, G.
    Briganti, A.
    Shariat, S.
    Castellucci, P.
    Fanti, S.
    Ceci, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S175 - S176
  • [35] Stereotactic Body Radiation Therapy for Unfavorable Intermediate-and High-Risk Prostate Cancer: 3-Year Outcomes of a Phase II Trial
    Macias-Hernandez, V. A.
    Barrera-Mellado, I.
    Marti, C.
    Pont, A.
    Fernandez-Lara, A.
    Soria, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S105 - S106
  • [36] Use of 68Ga-PSMA-HBED-CC (68Ga-PSMA-11) PET/CT At Initial Staging For Intermediate And High-Risk Prostate Cancer
    dos Santos, G.
    Banchero, A.
    Leiva, J.
    Trindade, V.
    Savio, E.
    Vilche, S.
    Perez, L.
    Gambini, J.
    Duarte, P.
    Alonso, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S538 - S538
  • [37] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
    Tulsyan, Shruti
    Das, Chandan J.
    Tripathi, Madhavi
    Seth, Amlesh
    Kumar, Rajeev
    Bal, Chandrasekhar
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102
  • [38] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer
    Zhou, Chuanchi
    Tang, Yongxiang
    Deng, Zhihe
    Yang, Jinhui
    Zhou, Ming
    Wang, Long
    Hu, Shuo
    EJNMMI RESEARCH, 2022, 12 (01)
  • [39] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer
    Tang, Yongxiang
    Yang, Jinhui
    Zhou, Chuanchi
    Hu, Shuo
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [40] Staging with [68Ga]Ga-PSMA-11 PET/CT in patients with intermediate and high-risk prostate cancer prior surgery: correlation with histopathology
    Rosales, J. J.
    Bastidas, J. F.
    Bronte, A.
    Betech-Antar, V.
    Minguez, F.
    Pareja, F.
    Guillen, E. F.
    Diez-Caballero, F.
    Minana, B.
    Arbizu, J.
    Rodriguez-Fraile, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S483 - S483
12345